NeuroPrex Company
NeuroPrex develops a non-invasive magnetic stimulation device for treating major depression and other neurological disorders.
Technology:
P4 Medicine
Industry:
Mental health
Headquarters:
London, England, United Kingdom
Founded Date:
2012-01-01
Employees Number:
1-10
Investors Number:
1
Total Funding:
€50K
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Register and Claim Ownership